| Total (n = 95) | Alive (n = 32) | Dead (n = 63) | p |
Maleb | 63 (66.3%) | 23 (72%) | 40 (63.5%) | 0.4 |
Average age (years)a | 68 ± 13 | 67.2 ± 16 | 68.4 ± 11 | 0.67 |
Age ≥ 65 year old | 16 (28.6%) | 16 (50%) | 40 (65.6%) | 0.14 |
Intensive care managementb | 42 (44%) | 1 (3%) | 41 (65%) | ˂0.001 |
Comorbidities |
|
|
|
|
AH | 31 (32.6%) | 12 (37.5%) | 19 (30.2%) | 0.47 |
Diabetesb | 32 (33.7%) | 9 (28%) | 23 (36.5%) | 0.4 |
Obesityb | 6 (6.3%) | 0 (%) | 6 (9.5%) | 0.07 |
Cancerb | 3 (3.2%) | 0 (0%) | 3 (4.8%) | 0.2 |
Smokingb | 7 (7.4%) | 2 (6.3%) | 5 (8%) | 0.7 |
Symptoms |
|
|
|
|
Fever | 69 (72.6%) | 23 (72%) | 46 (73%) | 0.9 |
Headacheb | 83 (87.4%) | 27 (84.4%) | 56 (89%) | 0.5 |
Dyspneab | 72 (75.8%) | 18 (56.3%) | 54 (85.7%) | 0.002 |
Anosmia/Ageusiab | 36 (38%) | 18 (56.3%) | 18 (28.6%) | 0.009 |
Clinical examination |
|
|
|
|
GCSa | 13 ± 3.7 | 15 ± 0.5 | 12 ± 4 | 0.004 |
Temperaturea | 37.4 ± 2 | 37.2 ± 2.6 | 38 ± 1.7 | 0.47 |
SBPa (cmhg) | 12.3 ± 1.4 | 12.5 ± 1 | 12 ± 1.5 | 0.17 |
DBPa (cmhg) | 7 ± 1 | 7 ± 1 | 6.6 ± 0.9 | 0.007 |
HRa (Beat/minute) | 89 ± 17 | 86 ± 8.8 | 80 ± 1 | 0.76 |
RRa (Breath/minute) | 25 ± 6 | 22 ± 5 | 26 ± 6 | 0.01 |
SpO2a (%) | 82.5 ± 10.7 | 86 ± 9 | 80.7 ± 11 | 0.02 |
Blood creatininec | 32 [17 - 64] | 15 [14 - 25] | 39 [24.5 - 65.5] | 0.007 |
Stage AKIb |
|
|
| ˂0.001 |
Stage 1 | 20 (21%) | 15 (47%) | 5 (8%) |
|
Stage 2 | 11 (11.6%) | 6 (18.8%) | 5 (8%) |
|
Stage 3 | 64 (67.4%) | 11 (34.4%) | 53 (84%) |
|
Lymphocytesc (Element/mm | 780 [548 - 1098] | 927 [620 - 1320] | 781 [495 - 1043] | 0.08 |
White cellsc (Element/mm3) | 9175 [5785 - 13,578] | 10,983 [5803 - 11,705] | 11,080 [5740 - 13,904] | 0.9 |
Hemoglobina (g/dl) | 12.2 ± 2.2 | 12 ± 2.2 | 12.7 ± 2.2 | 0.6 |
Plateletsc (Element/mm3) | 206,000 [146,000 - 303,000] | 211,500 [146,750 - 263,500] | 206,000 [143,000 - 309,000] | 0.86 |
CRPc (mg/l) | 159 [94.8 - 284] | 152 [92 - 279] | 183 [98 - 290] | 0.4 |
D-Dimerc (ng/ml) | 1700 [740 - 3800] | 1320 [540 - 2200] | 2010 [960 - 4733] | 0.16 |
Fibrinogena (g/l) | 7 [5.5 - 8] | 6.6 ± 1.7 | 7 ± 2.5 | 0.7 |
Ferritinec (ng/ml) | 984 [568 - 1681] | 979 [454 - 1312] | 986 [613 - 1757] | 0.3 |
Chest CT scan |
|
|
| ˂0.001 |
Extent of lesions ≥50%b | 54 (67.5%) | 7 (28%) | 49 (89%) |
|
Oxygenotherapyb |
|
|
| ˂0.001 |
Oxygen goggles | 14 (15%) | 13 (40.6%) | 1 (1.6%) |
|
High concentration mask | 46 (49%) | 13 (40.6%) | 33 (53.2%) |
|
Non-invasive ventilation | 17 (18%) | 1 (3%) | 16 (25.8%) |
|
Intubation | 10 (10%) | 0 | 10 (16.1%) |
|
≥2 antibiotiquesb | 40 (46.5%) | 9 (32%) | 31 (53.4%) | 0.06 |
Corticotherapyb |
|
|
| ˂0.001 |
Prednisolone | 7 (8.6%) | 7 (30.4%) | 0 (%) |
|
Dexamethasone | 8 (10%) | 0 (%) | 8 (13.8) |
|
Methylprednisolone | 66 (81.4%) | 16 (69.6%) | 50 (86.2%) |
|
Hemodialysisb | 20 (21%) | 1 (3%) | 19 (30.2%) | 0.002 |